Immunome (IMNM) Change in Acquisitions & Divestments (2024 - 2025)

Immunome (IMNM) posted Change in Acquisitions & Divestments of $125.0 million for Q3 2025, up 108.33% on a QoQ basis from $60.0 million in Q2 2025, and up 316.67% year-over-year from $30.0 million in Q3 2024.

Immunome (IMNM) Change in Acquisitions & Divestments (2024 - 2025) Analysis & Trends

Immunome's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $125.0 million for Q3 2025.

  • Quarterly Change in Acquisitions & Divestments rose 316.67% year-over-year to $125.0 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $185.0 million (changed N/A YoY) and the FY2025 annual result came in at $200.0 million, up 29.03% from the prior year.
  • Change in Acquisitions & Divestments was $125.0 million for Q3 2025 at Immunome, up from $60.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $125.0 million in Q3 2025 and bottomed at $15.0 million in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Immunome 2.59 Bn 2.00 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 125.00 Mn
Sep 30, 2025 125.00 Mn
Jun 30, 2025 60.00 Mn
Jun 30, 2025 60.00 Mn
Mar 31, 2025 15.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 85.00 Mn
Dec 31, 2024 85.00 Mn
Sep 30, 2024 30.00 Mn
Sep 30, 2024 30.00 Mn